Tips

美迪西匯總整理了11月生物醫(yī)藥行業(yè)會議供參考交流。同時，我們將計劃參與海內(nèi)外6場會議：

Medicilon Booth#1135

Ready to Meet Medicilon at SITC's 38th Annual Meeting & Pre-Conference Programs (SITC2023)?

We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.

Cellular immunotherapy has developed by leaps and bounds in recent years, providing a cure for many difficult-to-treat cancers. Medicilon has built a one-stop service platform for the preclinical R&D of cellular immunotherapies, covering a variety of immunotherapy methods including CAR-T, TCR-T and CAR-NK. Using a wealth of animal models and a variety of advanced analysis techniques, comprehensively considering the characteristics of different research projects, Medicilon has completed numerous pre-clinical projects for clients worldwide.

Date: November 1-5, 2023

Location: San Diego Convention Center

2023SAPA-China年會

主題一：人工智能(AI)賦能與加速小分子藥創(chuàng)新，11月3日 16:10-16:50

主題二：AlphaFold開創(chuàng)生物大分子藥AI新時代，11月4日 11:30-12:00

美中藥協(xié)中國分會（SAPA-China）2023年會茲定于2023年11月3-4日在蘇州高新區(qū)舉行。

SAPA是活躍于中美兩地最大的以華人為主的生物醫(yī)藥專業(yè)組織之一。協(xié)會的宗旨是推動生物醫(yī)藥科學(xué)與技術(shù)的發(fā)展，促進(jìn)產(chǎn)業(yè)投資及商務(wù)合作，普及公眾健康教育，協(xié)助會員職業(yè)生涯的發(fā)展。SAPA總部位于美國新澤西·大紐約地區(qū)，同時設(shè)有美國新英格蘭區(qū)(波士頓NE)分會、大費城地區(qū)(費城GP)分會、華盛頓特區(qū) (DC)分會、康州(CT)分會、中西部(芝加哥 MW)和中國(China)分會。SAPA自成立以來，為生物醫(yī)藥及健康行業(yè)國際交流搭建了一座橋梁，為推動跨國企業(yè)、中國本土企業(yè)和國際創(chuàng)新創(chuàng)業(yè)的技術(shù)交流和商務(wù)合作做了大量的工作，在北美和中國建立起了良好的聲譽和受到廣泛的尊敬。

今年是SAPA成立30周年。我們很榮幸的請到了生命科學(xué)領(lǐng)域著名的院士，頂尖的科學(xué)家，成功的企業(yè)家和投資者200余位作為我們的年會演講及圓桌論壇嘉賓。特別高興的是，我們也邀請了來自海外十余位多年從事生物醫(yī)藥研究的一流科學(xué)家參會，和我們共同探討創(chuàng)新藥的前沿科學(xué)進(jìn)展。

今年蘇州年會的主旨是“生物醫(yī)藥無國界，創(chuàng)新合作向未來”。兩天半的會議包括11月2日下午的會前會，3日上午的主會場（國際和國內(nèi)視角: 新形勢下創(chuàng)新藥發(fā)展），3日下午和4日整天，共12個論壇，31個主題分享交流。

第八屆制藥工藝論壇

本次會議將以“精準(zhǔn)化學(xué)與綠色制藥”為主題，繼續(xù)秉承“一線一流，著重實踐”原則，關(guān)注藥品制造領(lǐng)域的各種關(guān)鍵技術(shù)難題，邀請國內(nèi)外具有豐富經(jīng)驗的知名專家進(jìn)行經(jīng)驗分享和深入探討，旨在通過總結(jié)提煉醫(yī)藥企業(yè)在研發(fā)、生產(chǎn)、制造過程中有實效、可推廣的實踐案例，為降本、提質(zhì)、增效開辟新方法，為實現(xiàn)綠色制藥拓展新思路，持續(xù)推動制藥行業(yè)轉(zhuǎn)型升級，助力我國從制藥大國轉(zhuǎn)變?yōu)橹扑帍妵?/p>

APM2023第四屆亞洲制藥產(chǎn)業(yè)大會

由上海市生物醫(yī)藥產(chǎn)業(yè)發(fā)展領(lǐng)導(dǎo)小組辦公室指導(dǎo)，上海生物醫(yī)藥產(chǎn)業(yè)促進(jìn)中心、上海市生物醫(yī)藥科技發(fā)展中心、上海醫(yī)藥行業(yè)協(xié)會、上海士研管理咨詢有限公司聯(lián)合主辦的 2023 APM 第四屆亞洲制藥產(chǎn)業(yè)大會將于 11 月 9-10 日在上海召開！

本次大會以「創(chuàng)新驅(qū)動，韌性前行」為主題，將匯聚制藥百強專家，650+行業(yè)同仁，以主題演講、圓桌討論、技術(shù)路演等形式，帶領(lǐng)大家走進(jìn)藥品工業(yè)生產(chǎn)視角，呈現(xiàn)一場精彩絕倫的思想盛會，促進(jìn)了行業(yè)的融合與合作。

2023第七屆circRNA研究與產(chǎn)業(yè)論壇

circRNA，研究十年，從零開始，但發(fā)展迅猛，已成為生命科學(xué)及生物制藥領(lǐng)域的新興產(chǎn)業(yè)。circRNA功能機制、治療靶點等諸多科研成果正積極推動新的轉(zhuǎn)化方向和應(yīng)用領(lǐng)域。circRNA技術(shù)在傳染病疫苗、腫瘤疫苗、CAR-T療法、蛋白替代療法等領(lǐng)域均有突破性進(jìn)展。circRNA產(chǎn)研正在迎來發(fā)展的黃金期，持續(xù)受到各界關(guān)注!

“circRNA研究與產(chǎn)業(yè)論壇”自2015年創(chuàng)辦，是國內(nèi)唯一聚焦circRNA細(xì)分領(lǐng)域的專業(yè)論壇。打造高水平、高質(zhì)量、高精準(zhǔn)的生態(tài)圈層，促進(jìn)最新技術(shù)的傳播與發(fā)展，帶動科研與產(chǎn)業(yè)相結(jié)合。我們將攜手業(yè)內(nèi)大咖，共話科研新成果、同啟產(chǎn)業(yè)新征程！

張江細(xì)胞與基因治療產(chǎn)業(yè)國際峰會

2023年11月11-12日，由上海張江（集團(tuán)）有限公司、中國科學(xué)院深圳先進(jìn)技術(shù)研究院合成生物學(xué)研究所聯(lián)合主辦的“第四屆張江細(xì)胞與基因治療產(chǎn)業(yè)峰會暨第四屆合成免疫學(xué)前沿論壇”將于張江科學(xué)會堂（?？坡?393號）舉行。

歷時三年，峰會已成為中國細(xì)胞與基因領(lǐng)域中最具影響力的活動品牌之一，為助推上海生物醫(yī)藥產(chǎn)業(yè)的高速發(fā)展，全力打響“上海制造”品牌作出貢獻(xiàn)，逐步發(fā)展成為我國細(xì)胞與基因治療全產(chǎn)業(yè)鏈合作交流平臺。

本次大會將秉持往屆大會精神，邀海內(nèi)外專家學(xué)者、業(yè)界同仁齊聚申城，共襄盛會。

Neuroscience 2023

Join Medicilon at Neuroscience 2023!

Scientists from around the world will congregate at Neuroscience 2023 to discover new ideas, share their research, and experience the best the field has to offer.

Medicilon Pharmacodynamics Department can deliver multiple nervous system models based on anti-depressants, anti-Alzheimer's drugs, sedative-hypnotic and anti-anxiety drugs, analgesics, anti-convulsants, anti-Parkinson's drugs, and anti-schizophrenia drugs. Those models can effectively evaluate innovative drugs at the molecular and cellular level, as well as ex vivo, and in vivo. The Department's advanced Cognition Wall Discrimination learning ensures uninterrupted tracking to determine changes in memory function in double transgenic mice during early-stage Alzheimer's disease and eliminates the disadvantages of the Morris water maze (MWM) in stress interference and short-time tests.

Dates: Saturday, November 11–Wednesday, November 15

Location: Walter E. Washington Convention Center in Washington, D.C.

2023 USTCBAA Boston Technology Summit

Join Medicilon at the 2023 USTCBAA Boston Technology Summit

As one of the global centers for education, technology, and innovation, Boston provides us with a unique platform to collectively envision the future of technology and bring together the wisdom and strength of our alumni community. The 2023 USTCBAA Boston Technology Summit will cover four major themes: artificial intelligence, biomedicine, quantum physics, and financial investments, with the aim of presenting an inspiring and exchange-promoting technological feast for our community in new England area. This year's Summit will build upon the success of the Summit in 2022, commencing with an opening remark by Professor Xue Tian (Class of 9500), Assistant to the President of the University of Science and Technology of China and recipient of the Scientific Exploration Award.

During the conference, our EVP and Head of IDSU, Dr. Xuedong Dai will give a wonderful speech.

Date: November 12th, 2023 (9 AM-5 PM)

Location: MIT Building 10 Room 250 (222 Memorial Dr, Cambridge, MA 02139)

ACT 44th Annual Meeting

Join Medicilon for American College of Toxicology (ACT) 44th Annual Meeting.

The conference starts from November 12-15 at Orlando, Florida.

Medicilon team will be present throughout the conference. Medicilon’s state-of-the-art facilities are fully AAALAC-accredited. With state-of-the-art platforms and experienced scientists, Medicilon ensures that drug efficacy and safety assessments are conducted in the most professional manner while meeting the global regulatory standard. From stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible service options to assist biopharmaceutical clients efficiently reach their development milestones. Our toxicology research can be carried out according to non-GLP or GLP standards. By the end of 2022, there are already 12 full-set IND projects done in Medicilon (including API, formulation, PD, PK, and safety assessment).

Date: November 12-15, 2023

Location: Orlando, Florida

CIS-Asia 第十五屆化學(xué)制藥國際峰會

CIS-Asia2023|第十五屆化學(xué)制藥國際峰會-亞洲，聚焦化學(xué)創(chuàng)新藥，改良新藥和仿制藥研發(fā)。峰會連續(xù)2天，9個論壇同時進(jìn)行，將邀請120余位國際國內(nèi)大咖菁英，共同探討化學(xué)創(chuàng)新藥的研發(fā)技術(shù)和趨勢，改良型新藥領(lǐng)域最新突破，新形勢下仿制藥開發(fā)及競爭壁壘分析，分享最新成果和經(jīng)驗，以及藥物研發(fā)技術(shù)細(xì)節(jié)，助力醫(yī)藥研發(fā)。

EFMC-ISCB 2023

Medicilon Booth #8

We look forward to meeting you at EFMC-ISCB 2023!

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the Swiss Chemical Society, Division for Medicinal Chemistry & Chemical Biology (DMCCB) will be organising the International Symposium on Chemical Biology (EFMC-ISCB) on November 16-18, 2023 in Basel, Switzerland.

Taking over the successful series launched by the NCCR Chemical Biology, the meeting will continue its tradition of high scientific quality and bring together leading scientists to showcase the latest advances in the field of chemical biology. The symposium will be co-chaired by Dr Yves P. Auberson (Novartis, CH) and Prof. Maja K?hn (University of Freiburg, DE). The programme will include plenary and invited lectures, short communications selected from submitted abstracts, a poster session, and a commercial exhibition - with ample time for discussion and networking. The programme will include the following sessions:

?Chemical Immunology & Checkpoint Inhibitors

?Chemical Proteomics in Drug Discovery

?Chemically Induced Proximity

?Computational Chemical Biology (LS-EuChemS Session)

?New Understanding of Post-translational Modifications

?Protein Conformations: Beyond the Ground State

?Target Engagement and Mechanism of Action Determination

?Targeting Metabolism (ICBS Session)

For each of the above topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

Medicilon drug discovery services include chemistry (synthetic chemistry, medicinal chemistry) and biology. In terms of chemistry, it can undertake multi-dimensional business such as custom synthesis, compound library construction, SAR compound synthesis and screening, compound structure and biological activity optimization.

The medicinal chemistry team deeply cross-integrates chemistry and biology into each project, and flexibly uses the powerful expertise of computational chemistry to aid the compound design process. At the same time, Medicilon extensively uses advanced drug discovery technology, including AI, PROTAC, ADC antibody drug conjugation technology, etc. Medicilon efficiently promotes customers' drug research and development projects, controls costs, and improves quality!

We look forward to welcoming you in Basel!

Date: November 16-18, 2023

Location: Basel, Switzerland

第五屆生物工藝產(chǎn)業(yè)年度峰會

Bio-ONE深耕生物工藝四年多，累積匯聚工藝匠人4000多人。今年特別提出“簡化 優(yōu)化 強化”三大策略，希望通過這三大策略的攻關(guān)求索，結(jié)合智能化制造技術(shù)、結(jié)合工藝匠人技術(shù)躍升、結(jié)合公司精益運營經(jīng)驗，推動上下游全流程工藝突破，進(jìn)一步提升藥品質(zhì)量與研發(fā)效率。

2023年11月22-23日（周三、周四），由華東理工大學(xué)和佰傲谷BioValley聯(lián)合主辦的生物工藝的行業(yè)標(biāo)桿會議——2023第五屆生物工藝產(chǎn)業(yè)年度峰會（Bio-ONE2023）將在上海舉辦。

本次峰會以簡化、優(yōu)化、強化為主旨，聚焦全球最新工藝技術(shù)，囊括抗體、細(xì)胞與基因治療、核酸藥物等多個領(lǐng)域，共研工藝放大與商業(yè)化的最優(yōu)解。

BIONNOVA北京創(chuàng)新論壇

2023年11月23-24日，「BIONNOVA北京創(chuàng)新論壇」將召集2000+創(chuàng)新合作決策者、120+前沿創(chuàng)新演講陣容、80+技術(shù)領(lǐng)軍企業(yè)，聚焦小分子、抗體與細(xì)胞與基因治療領(lǐng)域的最新研發(fā)動態(tài)、生產(chǎn)工藝變革、臨床試驗進(jìn)展、商業(yè)化等內(nèi)容，實現(xiàn)深度交流與價值碰撞，共創(chuàng)醫(yī)藥發(fā)展新未來。

值得一提的是，諾和諾德、雅培、諾誠健華、先聲藥業(yè)、中源協(xié)和已確認(rèn)作為本屆論壇的領(lǐng)銜支持單位，其公司高管也會來到BIONNOVA現(xiàn)場。丹序生物、偉德杰生物、偉杰信生物、億一生物、呈諾醫(yī)學(xué)、貝來生物、紐安津生物、合美醫(yī)藥、福貝生物等細(xì)胞、抗體、小分子等80余家頭部藥企、新興黑馬的相關(guān)CXO、高管及科研專家將作為演講嘉賓出席，在大會現(xiàn)場進(jìn)行主題分享。

中國（蘇州）國際生物醫(yī)藥產(chǎn)業(yè)博覽會

蘇州工業(yè)園區(qū)作為本次產(chǎn)業(yè)博覽會的舉辦地，經(jīng)過17年的積累將生物醫(yī)藥產(chǎn)業(yè)打造成蘇州的“一號產(chǎn)業(yè)”。園區(qū)以新藥研發(fā)和產(chǎn)業(yè)化為主，2022年產(chǎn)值達(dá)1368億元，集聚相關(guān)企業(yè)2300多家，包括24家已上市企業(yè)、40余家進(jìn)入上市梯隊企業(yè)。園區(qū)在創(chuàng)新型龍頭企業(yè)數(shù)量、創(chuàng)新型人才規(guī)模、獲批生物創(chuàng)新藥臨床批件數(shù)量、生物大分子藥物總產(chǎn)能、企業(yè)融資總額五項指標(biāo)均占全國20%以上，生物醫(yī)藥綜合競爭力位列全國第一方陣。

通過舉辦本次產(chǎn)業(yè)博覽會旨在為產(chǎn)業(yè)發(fā)展提出新模式、匯集新動能：一是探索支付端的改善和需求端的釋放，協(xié)調(diào)醫(yī)藥、醫(yī)療、醫(yī)保三醫(yī)聯(lián)動促進(jìn)醫(yī)療大健康消費進(jìn)一步發(fā)力，構(gòu)建健康消費內(nèi)循環(huán)指針；二是響應(yīng)“一帶一路”倡議，推動海外市場監(jiān)管指導(dǎo)下的技術(shù)底層互信互認(rèn)，為產(chǎn)業(yè)的產(chǎn)品、產(chǎn)能、技術(shù)出海鋪就高速公路，提高國際市場運營能力，拓展批量海外市場，組織支持醫(yī)藥出海。

2023BRD中國（上海）生物藥創(chuàng)新開發(fā)大會

2023 BRD中國(上海)生物藥創(chuàng)新開發(fā)大會，將于上海11月29-30日舉辦，特邀50+國內(nèi)生物醫(yī)藥領(lǐng)域知名大咖，本次大會圍繞以下6場專題會議展開，充分分享及研討熱門生物創(chuàng)新藥開發(fā)進(jìn)展突破及臨床經(jīng)典案例。

第八屆細(xì)胞生物產(chǎn)業(yè)大會

近年來，細(xì)胞療法、基因療法、外泌體和類器官等創(chuàng)新療法和技術(shù)快速發(fā)展，為多種慢病和難治性疾病提供了新的希望，應(yīng)用前景廣闊。政策、技術(shù)與市場等因素驅(qū)動我國細(xì)胞和生物醫(yī)藥產(chǎn)業(yè)發(fā)展進(jìn)入快車道。于此背景下，由正和會展等單位組織的CBIC第八屆細(xì)胞生物產(chǎn)業(yè)大會暨第六屆中國生物醫(yī)藥創(chuàng)新合作大會將于11月29-30日在成都隆重舉辦。

成都作為我國西部地區(qū)重要的生物醫(yī)藥成果轉(zhuǎn)化基地，出臺了眾多政策，支持生物醫(yī)藥產(chǎn)業(yè)發(fā)展，擁有多所醫(yī)藥專業(yè)高等院校、國家實驗室和研究所等科研機構(gòu)，以及一批具有活力的生技企業(yè)，這些為成都生物醫(yī)藥產(chǎn)業(yè)集群和發(fā)展奠定了良好的政策和產(chǎn)業(yè)基礎(chǔ)。本次大會將充分發(fā)揮成都作為生物醫(yī)藥產(chǎn)業(yè)創(chuàng)新中心的關(guān)鍵作用，覆蓋西南地區(qū)生物醫(yī)藥市場，整合各方資源，為參會者提供展示成果、交流經(jīng)驗、尋找合作機會的平臺。

屆時大會將重點圍繞干細(xì)胞、免疫細(xì)胞、類器官、基因治療、外泌體等領(lǐng)域的熱點話題開展數(shù)十場論壇。同時，一批生技企業(yè)將集中展出產(chǎn)業(yè)上中下游的新產(chǎn)品和服務(wù)，預(yù)計吸引1000余生物醫(yī)藥領(lǐng)域的醫(yī)院與科研單位、知名藥企、生物技術(shù)公司、投融資機構(gòu)的專家和代表蒞臨會場交流，打造一場高質(zhì)量的產(chǎn)業(yè)盛會。邀您出席，共襄盛會！

marketing@medicilon.com.cn
微信或郵件聯(lián)系我們